Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version
Journal article, Peer reviewed
MetadataShow full item record
Original versionKolotkin, R. L., Williams, V. S. L., Ervin, C. M., Williams, N., Meincke, H. H., Qin, S., . . . Fehnel, S. E. (2019). Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life‐Lite Clinical Trials Version. Clinical Obesity, 9(3). 10.1111/cob.12310
The Impact of Weight on Quality of Life‐Lite (IWQOL‐Lite) is widely used in evaluations of weight‐loss interventions, including pharmaceutical trials. Because this measure was developed using input from individuals undergoing intensive residential treatment, the IWQOL‐Lite may include concepts not relevant to clinical trial populations and may be missing concepts that are relevant to these populations. An alternative version, the IWQOL‐Lite Clinical Trials Version (IWQOL‐Lite‐CT), was developed and validated according to the US Food and Drug Administration's (FDA's) guidance on patient‐reported outcomes. Psychometric analyses were conducted to validate the IWQOL‐Lite‐CT using data from two randomized trials (NCT02453711 and NCT02906930) that included individuals with overweight/obesity, with and without type 2 diabetes. Additional measures included the SF‐36, global items, weight and body mass index. The IWQOL‐Lite‐CT is a 20‐item measure with two primary domains (Physical [seven items] and Psychosocial [13 items]). A five‐item Physical Function composite and Total score were also supported. Cronbach's alpha and intraclass correlation coefficients exceeded 0.77 at each time point; patterns of construct validity correlations were consistent with hypotheses; and scores demonstrated treatment benefit. The IWQOL‐Lite‐CT is appropriate for assessing weight‐related physical and psychosocial functioning in populations commonly targeted for obesity clinical trials. Qualification from the FDA is being sought for use of the IWQOL‐Lite‐CT in clinical trials to support product approval and labelling claims.
Copyright© 2019 Novo Nordisk A/S.
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal
Showing items related by title, author, creator and subject.
Causal Analysis of World Health Organization's Surgical Safety Checklist Implementation Quality and Impact on Care Processes and Patient Outcomes: Secondary Analysis From a Large Stepped Wedge Cluster Randomized Controlled Trial in Norway Haugen, Arvid Steinar; Wæhle, Hilde Valen; Almeland, Stian Kreken; Harthug, Stig; Sevdalis, Nick; Eide, Geir Egil; Nortvedt, Monica Wammen; Smith, Ingrid; Softeland, Eirik (Journal article; Peer reviewed, 2017)Objective: We hypothesize that high-quality implementation of the World Health Organization's Surgical Safety Checklist (SSC) will lead to improved care processes and subsequently reduction of peri- and postoperative ...
Sense of coherence as a resource in relation to health-related quality of life among mentally intact nursing home residents – a questionnaire study Drageset, Jorunn; Nygaard, Harald A.; Eide, Geir Egil; Bondevik, Margareth; Nortvedt, Monica W.; Natvig, Gerd Karin (Health and Quality of Life Outcomes, Peer reviewed; Journal article, 2008-10-21)Background Sense of coherence (SOC) is a strong determinant of positive health and successful coping. For older people living in the community or staying in a hospital, SOC has been shown to be associated with health-related ...
Movement quality evaluation and its correlation with recommended functional measures in hip osteoarthritis Olsen, Aarid Liland; Magnussen, Liv Heide; Skjærven, Liv Karin Helvik; Assmus, Jörg; Sundal, Mary Anne; Ostelo, Raymond W.; Strand, Liv Inger (Peer reviewed; Journal article, 2020)Hip osteoarthritis may cause compensational movement strategies that require extra physical and mental effort. Such aberrant functioning can be captured in movement quality evaluation. The objective of this study was to ...